https://helda.helsinki.fi/handle/10138/176370
Quote:Neurotrophic factors MANF (mesencephalic astrocyte-derived neurotrophic factor) and CDNF (cerebral dopamine neurotrophic factor) are currently among the most promising molecules for the treatment for Parkinson s disease (PD).
Quote:In summary, MANF should be considered as a possible therapeutic agent or a drug target for promoting functional recovery after stroke.